Results 131 to 140 of about 551,832 (300)

Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update

open access: yesHaemophilia, Volume 31, Issue 2, Page 247-262, March 2025.
ABSTRACT Background Von Willebrand disease (VWD) is an inherited bleeding disorder caused by deficient or dysfunctional von Willebrand factor (VWF). VWF replacement therapy is indicated in VWD management. Methods This systematic review was conducted to evaluate all available evidence of the efficacy, safety, dosing and consumption of pasteurized plasma‐
Carmen Escuriola Ettingshausen   +6 more
wiley   +1 more source

Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation [PDF]

open access: yes, 2016
This is an Accepted Manuscript of an article published by Taylor & Francis GroupNon-vitamin K antagonist oral anticoagulants (NOACs) reduce the risk of thromboembolism in patients with atrial fibrillation (AF).
Artman, Benjamin   +8 more
core   +1 more source

Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report. [PDF]

open access: yesNeurol Sci, 2022
Mancuso M   +11 more
europepmc   +1 more source

A Case of Allergic Fungal Rhinosinusitis With Intradural Extension and Cerebritis

open access: yes
Otolaryngology–Head and Neck Surgery, EarlyView.
Nathaniel Oberholtzer   +3 more
wiley   +1 more source

Extension Study With rVIII‐SingleChain in Previously Untreated Patients (PUPs) With Severe Haemophilia A

open access: yesHaemophilia, Volume 31, Issue 2, Page 214-223, March 2025.
ABSTRACT Introduction Clinical trials and real‐world evidence have demonstrated the efficacy and safety of rVIII‐SingleChain in previously treated patients with haemophilia A. Aim To investigate the safety and efficacy of rVIII‐SingleChain in previously untreated patients (PUPs).
Johnny Mahlangu   +13 more
wiley   +1 more source

The expanding burden of idiopathic intracranial hypertension

open access: yesEye, 2018
ObjectiveTo quantify the hospital burden and health economic impact of idiopathic intracranial hypertension.MethodsHospital Episode Statistics (HES) national data was extracted between 1st January 2002 and 31st December 2016.
S. Mollan   +4 more
semanticscholar   +1 more source

INTRACRANIAL CONPLICATIONS OF OTOGENOUS THROMBOSIS OF THE LATERAL SINUS

open access: yesNippon Jibiinkoka Gakkai Kaiho, 1965
Three cases of otogenous lateral sinus thrombosis were recored at the Oto-laryngological Department of Okayame University Medical School, during 1962.Although the introduction of sulfonamide or antibiotics has made remarkable reduction in the emergence of thrombosis or other otogenous intracranial complications, it seems that recently those ...
Tohru Tanaka, Naoya Fushimi, Motoo Onoda
openaire   +4 more sources

Clinical, Phenotypic and Genotypic Characteristics of Von Willebrand Disease in Afro‐Caribbeans: Results From a Study in Martinique Island, French West Indies

open access: yesHaemophilia, EarlyView.
ABSTRACT Background Several cohort studies have investigated the molecular basis of von Willebrand disease (VWD); very few have focused on the Afro‐Caribbean population. Objectives To determine the genotypic and phenotypic characterization of VWD in a large cohort of Afro‐Caribbean patients living in Martinique.
Marie‐Daniéla Dubois   +21 more
wiley   +1 more source

History and progress of endovascular treatment for intracranial aneurysms

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2017
With the development of new technology and new materials, endovascular therapy has become the main treatment of intracranial aneurysms. The 70-year development of intracranial aneurysms endovascular therapy mainly includes 3 stages: firstly, the electric
Xiang-yu CAO   +5 more
doaj  

Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe Haemophilia

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Patients with severe haemophilia A (HA) with no family history of haemophilia will be diagnosed upon their first bleeding event. Methods Herein, we studied the effects of lack of family history in HA and the subsequent delay of diagnosis on bleeding pattern and early treatment, as well as on the risk of inhibitor development.
Ana Mendoza   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy